Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

VivaGel studied for safety in men

Aug. 28, 2006

Ono patent discloses new compounds for treating HIV infection

Aug. 28, 2006

Trimeris and Roche report on new potent fusion inhibitors with potential for once-weekly dosing

Aug. 28, 2006

MK-0518 combination therapy yields HIV RNA reduction at 24 weeks

Aug. 28, 2006

NIH to study prime-boost approach in HIV

Aug. 24, 2006

Aptivus/ritonavir efficacious and safe in PI-resistant pediatric patients

Aug. 23, 2006

Preclinical studies confirm that bevirimat is non-teratogenic

Aug. 23, 2006

QD-3: a novel peptidic HIV-1 fusion inhibitor for drug-resistant viruses

Aug. 23, 2006

Vicriviroc demonstrates potent and sustained viral suppression in HIV

Aug. 23, 2006

Heidelberg Pharma report on improved efficacy of novel alovudine prodrug

Aug. 23, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026